Low-Dose Imaging Effective for Ruling Out CAD

Article

HealthDay News - Coronary computed tomography may provide alternative to catheter-based angiography

HealthDay News - Low-dose coronary computed tomography (CT) appears as sensitive as catheter-based angiography and may provide a non-invasive alternative to the latter for ruling out coronary artery disease (CAD) in symptomatic patients, according to a meta-analysis published in the March 15 issue of the Annals of Internal Medicine.

Moritz Wyler von Ballmoos, MD, PhD, MPH, of the Harvard School of Public Health in Boston, and colleagues analyzed 16 studies comprising 960 patients to summarize current evidence on the ability of low-dose coronary CT for ruling out CAD in symptomatic adults.

The researchers determined the sensitivity and specificity of the technique to be 1.00 and 0.89, respectively, at the patient level. The pooled vessel- and segment-level estimates had lower sensitivity and higher specificity than did the patient-level estimates. The researchers found statistically significant heterogeneity between studies for vessel- and segment-level estimates, and this seemed to be related to body mass index and prevalence of CAD, though not with CT scanner characteristics. The researchers concluded that evidence suggests low-dose coronary CT angiography matches catheter-based angiography's sensitivity with low radiation exposure and may be a valid alternative to catheter angiography for triaging symptomatic patients with a suspicion of CAD.

"This noninvasive technique is associated with a low effective radiation dose of 2.7 mSv. However, our meta-analysis is based on a small number of studies, many of which were done at a single academic site and presumably with the same expert operators. Further studies are therefore needed before widespread diffusion of the technology can be recommended," the authors write.

AbstractFull Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.